0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Rifampin and Digoxin: Possible Drug Interaction in a Dialysis Patient

Carlo Novi, MD; Franco Bissoli, MD; Vittorina Simonati, MD; Tiziano Volpini, MD; Ambrogio Baroli, MD
JAMA. 1980;244(22):2521-2522. doi:10.1001/jama.1980.03310220023017.
Text Size: A A A
Published online

ABSTRACT

To the Editor.—  We would like to describe a case we observed recently involving a possible drug interaction in a patient receiving long-term dialysis.

Report of a Case.—  A 36-year-old woman receiving long-term dialysis three times weekly for renal failure caused by bilateral urolithiasis experienced heart failure because of repeated pulmonary embolization. She was treated with intravenously given digoxin, administered at the end of each dialysis session according to the guidelines for the use of this drug in renal failure.1 She showed good clinical response and serum digoxin levels (measured radioimmunologically) within the usual therapeutic range.2During digoxin treatment, the patient had a reactivation of an old pulmonary tuberculous lesion; we started treatment with rifampin, 450 mg (about 10 mg/kg of body weight) daily, and isoniazid, 200 mg on the day of dialysis and 100 mg on the other days.One week after starting treatment with antituberculous drugs,

Topics

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

42 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();